Stocks Wall Street weighs in on Regeneron’s prospects By Investing.comMay 4, 2024 Regeneron (NASDAQ:) Pharmaceuticals, Inc. remains at the forefront of the biopharmaceutical industry with a strategic…
Stocks US appeals court reinstates Regeneron’s antitrust case against Novartis From ReutersMarch 18, 2024 NEW YORK (Reuters) – A U.S. appeals court on Monday revived Regeneron (NASDAQ:) Pharmaceuticals’ antitrust…
